跳至主要内容
临床试验/NCT02428322
NCT02428322已完成不适用

Randomized, Double-blind, Placebo Controlled Trial of Vitamin D3 Supplementation on Clinical, and Subjective Symptoms of Paediatric Asthma

Conor Kerley0 个研究点目标入组 53 人开始时间: 2013年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
53
主要终点
Paediatic Asthma Control Test (P-ACT)

研究概览

简要总结

Epidemiological and observational studies have linked vitamin D deficiency with increased asthma/allergy incidence . Vitamin D insufficiency (<75nmol/L) has been associated with increased incidence of severe childhood asthma. Further, high 25(OH)D levels were associated with reduced risk of recent hospitalization, lower use of anti-asthmatic medication and lower airway hyper-responsiveness in childhood asthmatics. The association between vitamin D and allergy and asthma appears to be stronger in children than adults, with some even suggesting that childhood asthma may may be caused by VDD.

详细描述

Asthmatic children will be recruited in winter. After baseline testing, children will be randomized to take 2,000iu vitamin D or placebo daily for 15 weeks. After the 15 weeks, testing will be repeated. Tests involve blood draws, questionnaires and breathing tests.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 16 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Previous clinical diagnosis of asthma
  • •Ability to perform pulmonary function tests
  • •Established on anti-asthmatic pharmacotherapy with no expected change

排除标准

  • •Use of medications that influence vitamin D metabolism or absorption
  • •Chronic, non-asthma medical issues e.g. endocrine, hepatic, renal, or bone-disease

研究组 & 干预措施

Placebo

Placebo Comparator

An identical placebo capsule daily for 15 weeks.

干预措施: Placebo (Dietary Supplement)

Intervention

Experimental

2,000iu vitamin D3 per day for 15 weeks

干预措施: Placebo (Dietary Supplement)

Intervention

Experimental

2,000iu vitamin D3 per day for 15 weeks

干预措施: VItamin D3 (Dietary Supplement)

结局指标

主要结局

Paediatic Asthma Control Test (P-ACT)

时间窗: 15 weeks

次要结局

  • Biochemical markers (25(OH)D, total IgE, total calcium, albumin, PTH, phosphate, hsCRP, IgA and ECP.(15 weeks)
  • Mini paediatric asthma quality of life questionnaire(15 weeks)
  • Global Initiative for Asthma Score(15 weeks)
  • Height velocity(15 weeks)
  • Pulmonary function(15 weeks)
  • Asthma Diary(15 weeks)

研究者

发起方
Conor Kerley
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Conor Kerley

PhD candidate

University of Dublin, Trinity College

相似试验